American Portfolios Advisors Cassava Sciences Inc Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Cassava Sciences Inc stock. As of the latest transaction made, American Portfolios Advisors holds 2,300 shares of SAVA stock, worth $4,784. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,300Holding current value
$4,784% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding SAVA
# of Institutions
131Shares Held
14.2MCall Options Held
962KPut Options Held
864K-
Black Rock Inc. New York, NY3.22MShares$6.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$4.51 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny984KShares$2.05 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY790KShares$1.64 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY613KShares$1.28 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $83.4M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...